Jerome L Sullivan

Summary

Country: USA

Publications

  1. ncbi request reprint Iron therapy and cardiovascular disease
    J L Sullivan
    Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA
    Kidney Int Suppl 69:S135-7. 1999
  2. pmc The big idea: the coxib crisis iron, aspirin and heart disease risk revisited
    Jerome L Sullivan
    Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA
    J R Soc Med 100:346-9. 2007
  3. ncbi request reprint Is homocysteine an iron-dependent cardiovascular risk factor?
    J L Sullivan
    Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA
    Kidney Int 69:642-4. 2006
  4. ncbi request reprint Is stored iron safe?
    Jerome L Sullivan
    Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, USA
    J Lab Clin Med 144:280-4. 2004
  5. doi request reprint Iron in arterial plaque: modifiable risk factor for atherosclerosis
    Jerome L Sullivan
    Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA
    Biochim Biophys Acta 1790:718-23. 2009
  6. ncbi request reprint Macrophage iron, hepcidin, and atherosclerotic plaque stability
    Jerome L Sullivan
    Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610, USA
    Exp Biol Med (Maywood) 232:1014-20. 2007
  7. ncbi request reprint [Current status of the iron hypothesis of cardiovascular diseases]
    Jerome L Sullivan
    Burnett College of Biomedical Sciences, University of Central Florida, Orlando, USA
    Recenti Prog Med 98:373-7. 2007
  8. ncbi request reprint Blood donation, iron depletion and vascular integrity
    Jerome L Sullivan
    Atherosclerosis 175:381; author reply 383. 2004
  9. ncbi request reprint Stored iron and vascular reactivity
    Jerome L Sullivan
    Arterioscler Thromb Vasc Biol 25:1532-5. 2005
  10. ncbi request reprint Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis
    Jerome L Sullivan
    Am Heart J 145:190-4. 2003

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Iron therapy and cardiovascular disease
    J L Sullivan
    Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, USA
    Kidney Int Suppl 69:S135-7. 1999
    ..In this article, the history and current status of the "iron hypothesis" on ischemic heart disease are briefly reviewed, followed by comments on iron management practices for renal patients...
  2. pmc The big idea: the coxib crisis iron, aspirin and heart disease risk revisited
    Jerome L Sullivan
    Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA
    J R Soc Med 100:346-9. 2007
  3. ncbi request reprint Is homocysteine an iron-dependent cardiovascular risk factor?
    J L Sullivan
    Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA
    Kidney Int 69:642-4. 2006
    ..There may be no vasculopathic effect of homocysteine without available reactive iron. Iron-dependent amplification of the vascular effects of homocysteine may be one of several mechanisms by which stored iron increases cardiac risk...
  4. ncbi request reprint Is stored iron safe?
    Jerome L Sullivan
    Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, USA
    J Lab Clin Med 144:280-4. 2004
  5. doi request reprint Iron in arterial plaque: modifiable risk factor for atherosclerosis
    Jerome L Sullivan
    Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA
    Biochim Biophys Acta 1790:718-23. 2009
    ..The reviewed findings support the concept that arterial plaque iron is a modifiable risk factor for atherogenesis...
  6. ncbi request reprint Macrophage iron, hepcidin, and atherosclerotic plaque stability
    Jerome L Sullivan
    Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida 32610, USA
    Exp Biol Med (Maywood) 232:1014-20. 2007
    ..The proposed effects of hepcidin and iron in plaque progression offer an explanation of the paradox of no increase in atherosclerosis in patients with hemochromatosis despite a key role of iron in atherogenesis in normal subjects...
  7. ncbi request reprint [Current status of the iron hypothesis of cardiovascular diseases]
    Jerome L Sullivan
    Burnett College of Biomedical Sciences, University of Central Florida, Orlando, USA
    Recenti Prog Med 98:373-7. 2007
    ..The FeAST trial adds urgency to the initiation of new studies to assess the impact of maintenance of complete iron depletion in the primary prevention of cardiovascular diseases...
  8. ncbi request reprint Blood donation, iron depletion and vascular integrity
    Jerome L Sullivan
    Atherosclerosis 175:381; author reply 383. 2004
  9. ncbi request reprint Stored iron and vascular reactivity
    Jerome L Sullivan
    Arterioscler Thromb Vasc Biol 25:1532-5. 2005
  10. ncbi request reprint Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis
    Jerome L Sullivan
    Am Heart J 145:190-4. 2003
  11. ncbi request reprint Iron chelation by green tea flavonoids and improved endothelial function in chronic smokers
    Luca Mascitelli
    Circ J 70:1523; author reply 1523-4. 2006
  12. doi request reprint Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques
    Wei Li
    Division of Experimental Pathology, Department of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
    Exp Biol Med (Maywood) 233:818-26. 2008
    ..The cytoplasmic overexpression of TfR1 may be the result of lysosomal dysfunction and ectopic accumulation of lysosomal cathepsin L caused by atheroma-relevant lipids in atherogenesis...
  13. ncbi request reprint Stored iron and myocardial perfusion deficits
    Jerome L Sullivan
    Am Heart J 143:193-5. 2002
  14. ncbi request reprint Iron reduction and cardiovascular outcomes
    Jerome L Sullivan
    JAMA 297:2075; author reply 2076. 2007
  15. ncbi request reprint The effect of polyphenols in olive oil on heart disease risk factors
    Luca Mascitelli
    Ann Intern Med 146:394; author reply 394-5. 2007
  16. ncbi request reprint Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus
    Luca Mascitelli
    Arch Intern Med 167:204-5; author reply 205. 2007
  17. ncbi request reprint Interactions of stored iron with traditional and inflammatory cardiovascular risk factors
    Jerome L Sullivan
    Atherosclerosis 167:169. 2003
  18. ncbi request reprint Hormone therapy and cardiovascular disease
    Jerome L Sullivan
    N Engl J Med 349:2075-6. 2003
  19. ncbi request reprint Re: Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer
    Jerome L Sullivan
    J Natl Cancer Inst 95:829-30; author reply 830. 2003